Antidiabetic agent 6
Antidiabetic agent 6 is a research compound that activates the PI3K/AKT pathway to stimulate GLUT4 translocation. It has demonstrated efficacy in reducing blood glucose levels in streptozotocin-induced diabetic rat models, supporting its use in diabetes research involving both cellular signaling and in vivo metabolic studies.
Product Specifications
Field of Research
Metabolism Research, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog